68 results
Page 3 of 4
F-3
xls232a
15 Oct 21
Shelf registration (foreign)
7:41am
6-K/A
EX-99.1
19xkj
15 Oct 21
Current report (foreign) (amended)
7:19am
6-K
EX-99.2
i77owaws zkv8g
15 Oct 21
Notice of General Meeting to be held on 1 November 2021
7:15am
6-K
EX-99.1
7be2 qqu12t
12 Aug 21
Current report (foreign)
4:38pm
6-K
EX-99.1
t1mw m158zt16kv
12 Aug 21
Silence Therapeutics Reports Half-Year 2021 Results
4:30pm
6-K
EX-99.1
r50fjk4q2kwtr 6r6q
7 Jun 21
Preclinical data at EHA support recently reported positive topline clinical data for SLN124 in healthy volunteers
7:15am
6-K
EX-99.1
3uwrc1z
25 May 21
Silence Therapeutics Receives Remaining $40 Million from AstraZeneca as Part of Upfront Investment for Ongoing siRNA Collaboration
6:30am
6-K
EX-99.1
lsj vklc4olw9p4xcy
19 May 21
Silence Therapeutics Announces Positive Data from GEMINI Phase 1 Study of SLN124 in Healthy Volunteers
6:30am
20-F/A
jh2s hpwajhuzw6o
29 Apr 21
Annual report (foreign) (amended)
4:26pm
424B4
7k0cd9nmcj8a0en307
12 Apr 21
Prospectus supplement with pricing info
11:12am
424B4
nbmwtyvjm8l
12 Apr 21
Prospectus supplement with pricing info
11:11am
POS AM
96ujvahl1
8 Apr 21
Prospectus update (post-effective amendment)
9:31am
POS AM
fxzvpj2psz30x1 a7u
8 Apr 21
Prospectus update (post-effective amendment)
9:18am
20-F
f26y3
30 Mar 21
Annual report (foreign)
5:22pm
424B7
uvq12sp0fq5r v7
15 Mar 21
Prospectus with selling stockholder info
10:07am
F-1/A
33du2555jwka201g3ws
11 Mar 21
Registration statement (foreign) (amended)
4:02pm
F-1
aun87u tut5ye1
8 Mar 21
Registration statement (foreign)
9:50pm
6-K
EX-99.2
cya8 o4sab
5 Feb 21
Securities Purchase Agreement
9:40pm
6-K
EX-99.1
lyirn0
5 Feb 21
Securities Purchase Agreement
9:40pm
POS AM
5946yn t6o
23 Sep 20
Prospectus update (post-effective amendment)
4:47pm